Hematology focuses on diseases of the blood, bone marrow, and lymphatic system. Learn about the diagnosis and treatment of anemia, leukemia, and lymphoma.
Send us all your questions or requests, and our expert team will assist you.
Diagnosis and evaluation of hemophilia is a critical first step for patients and families seeking effective management of this rare bleeding disorder. At Liv Hospital, our multidisciplinary team combines state‑of‑the‑art laboratory techniques with comprehensive clinical assessment to create a personalized care plan. More than 1 in 10,000 newborns worldwide is affected by hemophilia, making early detection essential for preventing joint damage and life‑threatening bleeds. This page outlines the step‑by‑step process used by our specialists, from initial history taking to advanced genetic testing, and explains how international patients can access our full suite of services.
International patients often wonder how the diagnostic pathway differs from standard care in their home countries. Our approach aligns with international guidelines while offering the convenience of coordinated logistics, interpreter support, and tele‑consultations. Whether you are newly diagnosed or seeking a second opinion, the information below will help you understand what to expect during the diagnosis and evaluation journey at Liv Hospital.
Hemophilia is an inherited deficiency of clotting factors, most commonly factor VIII (Hemophilia A) or factor IX (Hemophilia B). The severity of the disease is classified based on residual factor activity:
Typical clinical signs that prompt a diagnostic work‑up include prolonged bleeding after circumcision, excessive bruising, or recurrent hemarthrosis (bleeding into joints). In newborns, a delayed umbilical cord separation may be an early clue. Understanding these patterns allows clinicians to prioritize urgent testing and tailor the evaluation process.
Patients should communicate the following symptoms during the initial visit:
By documenting these details, the medical team can align the diagnostic pathway with the specific presentation, ensuring a thorough diagnosis and evaluation.
The first phase of diagnosis and evaluation focuses on a detailed medical history and physical examination. Our hematologists conduct a structured interview that captures bleeding episodes, family pedigree, and any prior treatments.
During the assessment, clinicians use a standardized bleeding assessment tool (BAT) to quantify bleeding severity. This tool assigns scores to various bleeding manifestations, helping to differentiate hemophilia from other coagulopathies.
Physical examination includes joint inspection for swelling, range‑of‑motion testing, and assessment for signs of chronic arthropathy. In addition, the physician checks for any skin lesions, mucosal bleeding, or signs of anemia that may influence further testing.
Laboratory evaluation is the cornerstone of diagnosis and evaluation. The first test is a routine coagulation screen, which includes prothrombin time (PT), activated partial thromboplastin time (aPTT), and a complete blood count (CBC). In hemophilia, PT is typically normal while aPTT is prolonged, reflecting deficiency of the intrinsic pathway.
Following the screening, specific factor assays quantify the activity of factor VIII or IX. Results are expressed as a percentage of normal activity, guiding classification into severe, moderate, or mild disease.
In rare cases, a mixed deficiency may be suspected, prompting additional tests such as von Willebrand factor antigen and activity, or fibrinogen levels. All samples are processed in Liv Hospital’s JCI‑accredited laboratory, ensuring rapid turnaround and high analytical accuracy.
While laboratory data confirm the clotting factor deficiency, imaging studies assess the impact of bleeding on joints and soft tissues. Ultrasound is the first‑line modality for detecting early hemarthrosis, especially in pediatric patients.
For comprehensive joint assessment, magnetic resonance imaging (MRI) provides detailed visualization of synovial hypertrophy, cartilage loss, and hemosiderin deposition. MRI findings are incorporated into the Hemophilia Joint Health Score (HJHS), which tracks disease progression and treatment response.
In addition to musculoskeletal imaging, liver function tests are performed when patients receive clotting factor concentrates derived from plasma, to monitor for potential hepatic complications.
Genetic analysis plays a pivotal role in the long‑term diagnosis and evaluation strategy, especially for families planning future pregnancies. DNA sequencing identifies specific mutations in the F8 (Hemophilia A) or F9 (Hemophilia B) genes, enabling carrier detection and prenatal diagnosis.
Our genetic counselors discuss inheritance patterns—X‑linked recessive transmission—and the implications for siblings and future offspring. They also review options such as pre‑implantation genetic diagnosis (PGD) and prenatal testing, providing a clear roadmap for families seeking to prevent disease transmission.
Results are delivered in a confidential, culturally sensitive session, with interpreter support available for non‑English speaking patients. The counseling session concludes with a personalized care plan that integrates genetic findings with clinical management.
Diagnosis and evaluation at Liv Hospital does not end with test results. A coordinated care pathway ensures that every patient receives comprehensive, ongoing support.
Our international patient office arranges airport transfers, hotel bookings, and interpreter services, allowing patients to focus solely on their health. Tele‑medicine follow‑ups are available for patients returning to their home countries, ensuring continuity of care.
Liv Hospital is a JCI‑accredited private facility in Istanbul, dedicated to serving international patients with complex hematologic conditions. Our team combines world‑class expertise, cutting‑edge diagnostics, and a seamless 360‑degree patient support system. From the moment you arrive, we coordinate appointments, transportation, interpreter services, and comfortable accommodation, allowing you to receive top‑tier care without logistical stress.
Ready to schedule your comprehensive hemophilia assessment? Contact our international patient team today to arrange a personalized consultation and begin your journey toward optimal health.
Send us all your questions or requests, and our expert team will assist you.
First, patients meet with a hematologist who records bleeding episodes, family history, and conducts a physical exam. A Bleeding Assessment Tool (BAT) quantifies severity. Laboratory screening includes PT, aPTT, and CBC, after which factor VIII or IX assays determine the specific deficiency. Imaging such as ultrasound or MRI evaluates joint health. In selected cases, inhibitor screening and genetic sequencing are performed to identify mutations and guide counseling. All results are reviewed by a multidisciplinary team to create a personalized care plan.
The Bleeding Assessment Tool records the frequency and intensity of symptoms like skin bruising, oral bleeding, joint bleeds, and post‑surgical hemorrhage. Each category receives a numeric score; higher totals indicate more severe bleeding tendencies. By standardizing symptom reporting, BAT helps identify patients who need further laboratory testing and supports classification into severe, moderate, or mild hemophilia. It also serves as a baseline for monitoring treatment response over time.
Ultrasound offers a quick, bedside assessment of joint effusions and early hemarthrosis, especially in children. For comprehensive evaluation, MRI visualizes synovial hypertrophy, cartilage loss, and hemosiderin deposition, which are incorporated into the Hemophilia Joint Health Score (HJHS). CT scans are reserved for complex skeletal injuries. Imaging results guide physiotherapy, prophylactic factor replacement, and surgical decisions.
Ultrasound offers a quick, bedside assessment of joint effusions and early hemarthrosis, especially in children. For comprehensive evaluation, MRI visualizes synovial hypertrophy, cartilage loss, and hemosiderin deposition, which are incorporated into the Hemophilia Joint Health Score (HJHS). CT scans are reserved for complex skeletal injuries. Imaging results guide physiotherapy, prophylactic factor replacement, and surgical decisions.
The International Patient Office coordinates travel logistics, including airport pickups and accommodation near the hospital. Professional interpreters are available for consultations and counseling sessions. Patients receive a personalized itinerary that aligns appointments with their travel schedule. After discharge, tele‑medicine appointments allow continued monitoring by Liv Hospital’s hematology team, ensuring continuity of care across borders.
The International Patient Office coordinates travel logistics, including airport pickups and accommodation near the hospital. Professional interpreters are available for consultations and counseling sessions. Patients receive a personalized itinerary that aligns appointments with their travel schedule. After discharge, tele‑medicine appointments allow continued monitoring by Liv Hospital’s hematology team, ensuring continuity of care across borders.
BlogHematologyFeb 19, 2026A complete blood count is a common test to check overall health. It helps find issues like anemia, infectio...
BlogHematologyFeb 19, 2026Thin blood, also known as thrombocytopenia, happens when you have too few platelets. Platelets help your bl...
BlogHematologyFeb 19, 2026Hemophilia is a genetic disorder that makes it hard for the body to form blood clots. It affects people all...
BlogAnemiaFeb 19, 2026Are you always tired, dizzy, or have brittle nails? Poor iron absorption might be the reason. It’s a ...
BlogHematologyFeb 19, 2026The Rule of Three is key in hematology. It helps labs check if a complete blood count (CBC) is right. It sa...
Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.
Start Chat on WhatsApp or call us at +90 530 510 71 24
